Please assess the completion status of the following clinical trial:

Trial Title: Effects of Anorexia Nervosa on Bone Mass in Adolescents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Females Only with Anorexia Nervosa and Amenorrhea 12-18 years~* Normal-weight girls 12-18 years with no past or present history of an eating disorder~Exclusion Criteria:~* Diseases affecting bone metabolism (including untreated thyroid disease, premature ovarian failure, diabetes, cancer, pituitary, renal disease or bone fracture within the past six months)~* Use of prescription medications affecting bone metabolism within three months~* Suicidality~* Psychosis~* Substance abuse~* Hematocrit \<30 %~* Potassium \<3.0 mmol/L~* Glucose \<50 mg/dl.

- Gender: FEMALE
- Minimum Age: 12 Years
- Maximum Age: 18 Years
- Healthy Volunteers: t

Study Arms:
- Physiologic estrogen replacement (Type: EXPERIMENTAL): Mature girls with anorexia nervosa (AN) (bone age 15 or greater): Transdermal estradiol (100 mcg) with cyclic progesterone (days 1-10 of each month).~Immature girls with AN (bone age less than 15 years): Ethinyl estradiol (3.75 mcg daily for the first 6 months, 7.5 mcg daily for the next 6 months, and 11.25 mcg daily for the final 6 months of the study
- Placebo (Type: PLACEBO_COMPARATOR): Placebo patches or pills

Based on this trial design, predict the completion outcome and termination type (if applicable).